Search

Search Results

• Epidemiological and clinical profiles of cutaneous leishmaniasis cases in Amhara National Regional State, Northwest Ethiopia: a multicenter retrospective study

  Bizuayehu Gashaw, Endalew Yizengaw, Endalkachew Nibret, Addisu Workineh, Adisu Abebe

  04-11-2024

  https://doi.org/10.4081/dr.2024.10089

  1316

  PDF: 804

  HTML: 166
• 

  A rare case of polypoid primary anorectal melanoma with subsequent giant stomach metastasis: A gastrointestinal involvement of both primary and metastatic mucosal melanoma

  Vincenzo De Giorgi, Federica Scarfi, Carlo Boselli, Giacomo Sacchetti, Nicola Natalizi, Danilo Castellano, Piero Covarelli

  28-07-2021

  https://doi.org/10.4081/dr.2021.9092

  2845

  PDF: 396

  HTML: 7

• The suitability of mesenchymal stem cells for treating immune-mediated inflammatory skin diseases: a systematic review

  Elena Pezzolo, Sara Di Leo, Paola Miceli, Alvise Sernicola, Luigi Naldi

  01-07-2025

  https://doi.org/10.4081/dr.2025.10112

  802

  PDF: 579

  HTML: 20

• Real-world experience with vismodegib and sonidegib in advanced basal cell carcinoma: a multicenter Italian study

  Mario Valenti, Sara Di Giulio, Andrea Carugno, Pasquale Frascione, Angelo Valerio Marzano, Santo Raffaele Mercuri, Gianluca Nazzaro, Giulia Spallone, Giovanni Paolino, Marco Ardigò

  18-02-2025

  https://doi.org/10.4081/dr.2025.10196

  571

  PDF: 481

  HTML: 12

• Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective

  Alba Guglielmo, Maria Ludovica Deotto , Luigi Naldi , Giuseppe Stinco, Alessandro Pileri, Bianca Maria Piraccini, Anna Belloni Fortina, Andrea Sechi

  13-09-2023

  https://doi.org/10.4081/dr.2023.9839

  2692

  PDF: 982

  HTML: 31

• Spontaneous remission of Merkel cell carcinoma presenting with tertiary lymphoid structures in an immunocompetent patient

  Luigi Cerbone, Alessia Garau, Tiziana Borra, Paola Barbieri, Rebecca Parisi, Claudia Leporati, Marco Ghiglione, Federica Grosso

  15-05-2026

  https://doi.org/10.4081/dr.2026.10799

  187

  PDF: 78

• Publication trends in vitiligo research from 1991 to 2024: a comprehensive bibliometric analysis

  Yuh-Shan Ho, Hilla Rosenberg, Jonathan Shapiro, Amir Horev

  04-05-2026

  https://doi.org/10.4081/dr.2026.10656

  132

  PDF: 79
• 

  25 | A phase II, open-label study to improve compliance and time of treatment after obtaining complete response through a tailored schedule of sonidegib in locally advanced basal cell carcinomas – the SONIBEC trial Monica Variolo^1|2, Carlo Resteghini^1|2, Sara Farinatti^1|2, Andrea Alberti³, Valeria Tovazzi³, Paola Queirolo⁴, Maristella Saponara⁴, Giuseppe Argenziano⁵, Riccardo Marconcini⁶, Ketty Peris⁷, Paola Savoia⁸, Maria Chiara Tronconi¹, Iris Zalaudek⁹, Paolo Ascierto¹⁰, Francesco Spagnolo¹¹, Luigi Lorini¹, Cristina Gurizzan¹, Paolo Bossi^1|2 | ¹Medical Oncology and Haematology Unit, IRCCS Humanitas Research Hospital, Rozzano ^MI; ²Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan; ³Medical Oncology Unit, ASST Spedali Civili, Brescia; ⁴Division of Medical Oncology for Melanoma, Sarcoma, and Rare Tumors, IEO, European Institute of Oncology IRCCS, Milan; ⁵Unit of Dermatology, Luigi Vanvitelli University of Campania, Naples; ⁶Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa; ⁷Institute of Dermatology, Catholic University of the Sacred Heart, Rome, Italy; Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome; ⁸Department of Health Sciences, University of Eastern Piedmont, Novara; ⁹Department of Dermatology and Venereology, University of Trieste, Ospedale Maggiore, Trieste; ¹⁰Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples; ¹¹Department of Medical Oncology, IRCCS AOU San Martino-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy.

  Italian Melanoma Intergroup

  11-12-2025

  https://doi.org/10.4081/dr.2025.10767

  325
• 

  33 | A single center, real world experience with hedgehog pathway inhibitors in advanced basal cell carcinoma Giulia Gibilisco¹, Ramiz Anwar Rana¹, Vincenzo D’Alonzo¹, Maura Colucci^1|2, Monica Valente², Elisa Cinotti³, Giovanni Rubino⁴, Valentina Croce¹, Eleonora Carbonari¹, Matteo Ravara¹, Tommaso Sani¹, Maria Lo Fiego¹, Alessia Covre¹, Serena Cutarella¹, Roberto Cuomo⁵, Luca Grimaldi⁵, Pietro Rubegni³, Michele Maio^1|2, Anna Maria Di Giacomo^1|2 | ¹University of Siena; ²Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena; ³Dermatology Unit, Department of Medicine, Surgery and Neuroscience, University Hospital of Siena; ⁴Radiotherapy Unit, Department of Oncology, University Hospital of Siena; ⁵Plastic Surgery Unit, Department of Medicine, Surgery and Neuroscience, University Hospital of Siena; ⁶NIBIT Foundation Onlus, Genoa, Italy.

  Italian Melanoma Intergroup

  11-12-2025

  https://doi.org/10.4081/dr.2025.10775

  316